Gastrointestinal Diseases and Disorders News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Living in the Moment: Finding Inner Peace through the Practice of Mindfulness - Palm Beach Post



Palm Beach Post
 
Living in the Moment: Finding Inner Peace through the Practice of Mindfulness 
Palm Beach Post
It can serve as a complement to treatment by helping to lower stress levels that are often a contributing factor to various conditions, including: cancer, high blood pressure, heart disease, asthma, gastrointestinal problems, psoriasis, and auto immune ...

 


Imperial partners with Heptares to search for new gut drugs - Imperial College London



Imperial College London
 
Imperial partners with Heptares to search for new gut drugs 
Imperial College London
"These groups provide the fundamental science and biological insights to the role of GPCRs in human disease to which Heptares can apply its world-leading GPCR-targeted drug discovery and translational medicine capabilities to generate new drug ...

and more » 


Global Enteral Feeding Devices Market 2018-2022 by Type, Age Group, Application, End User - Markets Insider



Global Enteral Feeding Devices Market 2018-2022 by Type, Age Group, Application, End User 
Markets Insider
The global enteral feeding devices market is projected to reach USD 3.19 Billion by 2022 from USD 2.39 Billion in 2017, growing at a CAGR of 6.0% during the forecast period. Factors such as rising healthcare costs; surge in the number of preterm births ...

and more » 


Heptares and Imperial tackle gastrointestinal tract disease - Business Weekly



Business Weekly
 
Heptares and Imperial tackle gastrointestinal tract disease 
Business Weekly
This collaboration aims to leverage the significant recent progress made in understanding how GPCRs in the GI tract can be modulated and will support the application of Heptares structure-based approaches to develop novel treatments for GI disorders ...

 


5 Presidents Who Hid Their Health Issues - History



History
 
5 Presidents Who Hid Their Health Issues 
History
He had allergies, stomach troubles and suffered from chronic back pain, which was aggravated by his WWII service and required numerous surgeries. The back injury allegedly happened in 1937 while he was a student at Harvard, and it initially ...

 


AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of ... - Markets Insider



AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of ... 
Markets Insider
BROOKLYN, N.Y., Jan. 18, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (?AzurRx? or the ?Company?), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, announced today that in ...

and more » 


Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal ... - GlobeNewswire (press release)



Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal ... 
GlobeNewswire (press release)
Enrolled patients had relapsed or refractory advanced HER2+ gastric or GEJ cancer with disease progression after or resistance to treatment with trastuzumab plus chemotherapy. Study patients were enrolled irrespective of PD-L1 expression status. A ...

and more » 


'Rise in GI diseases' - Daily Pioneer



Daily Pioneer
 
'Rise in GI diseases' 
Daily Pioneer
Decreasing fibre in the diet contributes to GI disorders. Habits like tobacco, pan masala has continued to cause more GERD, dyspepsia, oral and food pipe cancers. The unclean water and sanitation can cause waterborne diseases which typically involve ...

 


RedHill Biopharma Announces Final Results from Phase II Study with BEKINDA® for IBS-D - GlobeNewswire (press release)



RedHill Biopharma Announces Final Results from Phase II Study with BEKINDA® for IBS-D 
GlobeNewswire (press release)
RedHill promotes three gastrointestinal products in the U.S.: Donnatal® - a prescription oral adjunctive drug used in the treatment of IBS and acute enterocolitis; Esomeprazole Strontium Delayed-Release Capsules 49.3 mg - a prescription proton pump ...

and more » 


Gut-Brain Axis and Neuropsychological Disorders - News-Medical.net



News-Medical.net
 
Gut-Brain Axis and Neuropsychological Disorders 
News-Medical.net
The gastrointestinal system is considered our largest immune organ, but some of its products may be pathogenic to the central nervous system. This is explained by the existence of a gut-brain axis, which is a complex two-way communication network ...

and more »